
Nurix Therapeutics
Price & Volume
Stats
See moreOpen | $24.47 |
Previous Close | $24.26 |
Day Range | $23.93-$24.82 |
52W Range | $8.19-$24.88 |
Market Cap | $2.4B |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $71.7M |
Revenue Growth (YoY) | -66.1% |
Gross Profit (12 Mos) | -$259.5M |
Diluted EPS | -$3.17 |
News
See moreYahoo Finance • 2 days ago
Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value
Yahoo Finance • 6 days ago
Nurix Therapeutics (NRIX) Soars 16.4%: Is Further Upside Left in the Stock?
Yahoo Finance • 6 days ago
Nurix (NRIX) Climbs to 52-Week High — This Deal May Hold the Answer
Yahoo Finance • 16 days ago
Truist is Bullish on Nurix Therapeutics, Inc. (NRIX)
About
CEO | Dr. Arthur T. Sands M.D., Ph.D. |
Address | 1600 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 317 |